Profound Medical Corp T.PRN

Alternate Symbol(s): PROF

Technology Scientific & Technical Instruments

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp

Bullboard Posts

Comment by homerunstockon Jul 21, 2020 3:34pm

165 Views

Post# 31298078

RE:Promoting stocks gets you ignored ...

Yes and ignoring a homerun no brainer 10 bagger stock like Perimiter gift wrapped and handed to you makes you look no so smart so suck up your pride and arrogance and do your due diligence so easy to see the massive potential on the same scale as Profound to itself is great and will continue to over achieve

Bullboard Posts

A Look into the Future of Chronic Pain Management